tiprankstipranks
Advertisement

EFA - ETF AI Analysis

Compare

Top Page

EFA

iShares MSCI EAFE ETF (EFA)

Rating:66Neutral
Price Target:
EFA, the iShares MSCI EAFE ETF, has a solid overall rating driven mainly by high‑quality global leaders like ASML, HSBC, AstraZeneca, and Novartis, which show strong financial performance, positive earnings outlooks, and generally supportive technical trends. These strengths are partly offset by holdings such as Shell and Commonwealth Bank of Australia, where weaker revenue or cash flow trends, valuation concerns, and bearish or mixed technical signals introduce some risk. The main risk factor is the fund’s exposure to several large financial and healthcare names, where high leverage, overvaluation, or overbought conditions could weigh on future returns.
Positive Factors
Strong Top Holding Performance
Several of the largest positions, including ASML and BHP, have shown strong gains this year, helping support the ETF’s overall returns.
Broad International Diversification
The fund spreads its investments across many developed countries such as Japan, the UK, France, and Germany, which helps reduce reliance on any single market.
Large Asset Base
With a very high level of assets under management, the ETF benefits from strong investor interest and typically better trading liquidity.
Negative Factors
Mixed Performance Among Top Holdings
Some major positions like Roche and Nestlé have shown weak or negative performance this year, which can drag on the fund’s overall results.
Moderate Expense Ratio
The fund’s expense ratio is not especially low for a large, broad international ETF, meaning fees take a noticeable bite out of long-term returns.
Heavy Exposure to a Few Countries
A large portion of the portfolio is concentrated in markets like Japan and the UK, which can increase the impact of economic or political issues in those countries.

EFA vs. SPDR S&P 500 ETF (SPY)

EFA Summary

The iShares MSCI EAFE ETF (EFA) is a fund that lets you invest in many large and mid-sized companies in developed markets outside the U.S. and Canada. It follows the MSCI EAFE index and owns stocks from countries like Japan, the UK, France, and Australia across many sectors, including financials, industrials, and health care. Well-known holdings include Nestlé and HSBC. Someone might invest in EFA to diversify their portfolio internationally and reduce reliance on the U.S. market. A key risk is that its value can go up and down with global stock markets and currency swings.
How much will it cost me?The iShares MSCI EAFE ETF (EFA) has an expense ratio of 0.32%, meaning you’ll pay $3.20 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it provides broad exposure to developed international markets, which can involve higher operational costs compared to U.S.-focused funds.
What would affect this ETF?The iShares MSCI EAFE ETF could benefit from economic recovery in developed markets outside North America, particularly in Europe and Asia, as well as growth in sectors like financials and technology, which are heavily represented in its holdings. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially in sectors like financials and energy. Diversification across industries and countries provides some resilience, but global economic uncertainty remains a key risk.

EFA Top 10 Holdings

EFA leans heavily on a mix of European and Asia-Pacific blue chips, with ASML and Siemens doing much of the heavy lifting as they ride strong momentum in tech and industrials. BHP is also pulling its weight, helped by a firmer backdrop for commodities. On the flip side, defensive giants like Nestlé and AstraZeneca have been losing a bit of steam, while Commonwealth Bank has been a mild drag. Overall, the fund is broadly diversified across sectors, but its story is very much about developed markets outside North America, especially Europe.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.71%$2.05B€546.47B114.08%
76
Outperform
HSBC Holdings1.44%$1.09B£236.14B59.79%
80
Outperform
Roche Holding AG1.33%$1.01B$339.59B31.25%
73
Outperform
AstraZeneca1.33%$1.01B$290.33B33.16%
80
Outperform
Novartis AG1.30%$984.58MCHF218.09B26.43%
80
Outperform
Nestlé SA1.18%$891.59MCHF202.64B-7.29%
71
Outperform
Shell (UK)1.12%$849.23M£178.59B30.57%
73
Outperform
Siemens1.09%$829.77M€210.96B22.96%
74
Outperform
BHP Group Ltd1.03%$782.17MAU$305.45B74.38%
68
Neutral
Commonwealth Bank of Australia0.96%$726.82MAU$275.18B-6.30%
64
Neutral

EFA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
100.86
Positive
100DMA
100.94
Positive
200DMA
96.69
Positive
Market Momentum
MACD
0.81
Negative
RSI
58.03
Neutral
STOCH
84.88
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 103.05, equal to the 50-day MA of 100.86, and equal to the 200-day MA of 96.69, indicating a bullish trend. The MACD of 0.81 indicates Negative momentum. The RSI at 58.03 is Neutral, neither overbought nor oversold. The STOCH value of 84.88 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EFA.

EFA Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$77.51B0.32%
66
Neutral
$184.72B0.07%
65
Neutral
$30.46B0.33%
67
Neutral
$15.50B0.36%
65
Neutral
$11.56B0.20%
65
Neutral
$10.77B0.24%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EFA
iShares MSCI EAFE ETF
104.77
19.15
22.37%
IEFA
iShares Core MSCI EAFE ETF
EFV
iShares MSCI EAFE Value ETF
EFG
iShares MSCI EAFE Growth ETF
ESGD
iShares ESG Aware MSCI EAFE ETF
JIRE
JPMorgan International Research Enhanced Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement